{"id":2733,"date":"2025-05-09T09:10:43","date_gmt":"2025-05-09T09:10:43","guid":{"rendered":"https:\/\/nasoie.com\/?page_id=2733"},"modified":"2025-08-04T12:50:00","modified_gmt":"2025-08-04T12:50:00","slug":"guidelines-statements","status":"publish","type":"page","link":"https:\/\/cressettech1.com\/?page_id=2733","title":{"rendered":"Guidelines & Statements"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

\t<\/p>\n
\"\"<\/figure>\n

<\/p>\n

<\/p>\n

Guidelines & Statements<\/h1>\n

<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
<\/div>\n

<\/p>\n

\t<\/p>\n

NASOIE<\/h1>\n

\t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
August<\/b>2022<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

Consensus Statement on Thermal and Chemical Ablation of Thyroid Nodules and Neck Lesions <\/h2>\n

Thermal and chemical ablation techniques for the non-surgical treatment of thyroid nodules and neck lesions have been used internationally for decades, with only relatively recent interest and acceptance in the United States of America. This statement is intended to be an evolving document that provides a framework for the safe and effective practice of chemical and thermal ablation techniques for the management of thyroid nodules in the outpatient setting in the United States<\/pee> <\/p>\n

\t\t <\/p>\n
NORTH AMERICAN SOCIETY OF INTERVENTIONAL ENDOCRINOLOGISTS<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” width=”99.8%”]<\/p>\n

<\/p>\n
May<\/b>2022<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

Consensus Statement on Thermal and Chemical Ablation of Thyroid Nodules and Neck Lesions<\/h2>\n

Thermal and chemical ablation techniques for the non-surgical treatment of thyroid nodules and neck lesions have been used internationally for decades, with only relatively recent interest and acceptance in the United States of America. This statement is intended to be an evolving document that provides a framework for the safe and effective practice of chemical and thermal ablation techniques for the management of thyroid nodules in the outpatient setting in the United States<\/pee> <\/p>\n

\t\t <\/p>\n
NORTH AMERICAN SOCIETY OF INTERVENTIONAL ENDOCRINOLOGISTS<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
<\/div>\n

<\/p>\n

\t<\/p>\n

Other Societies<\/h1>\n

\t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
APRIL <\/b>2025<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

2024 International Expert Consensus on US-guided Thermal Ablation for T1N0M0 Papillary Thyroid Cancer | Radiology<\/h2>\n

\t Thermal ablation has started to gain acceptance as a therapeutic approach for the management of papillary thyroid cancer (PTC), mainly in the T1 stage (tumor size \u2264 2 cm in greatest dimension and limited to the thyroid). <\/pee> <\/p>\n

\t\t <\/p>\n
US-guided Thermal Ablation for T1N0M0 Papillary Thyroid Cancer<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
JUNE<\/b>2024<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

Brazilian Consensus on the Application of Thermal Ablation for Treatment of Thyroid Nodules<\/h2>\n

There is increasing interest in ultrasound-guided ablation treatments for thyroid diseases, including benign and malignant ones. Surgeons, radiologists, and endocrinologists carry out these treatments, and various organizations within these specialties have recently released multiple international consensus statements and clinical practice standards. The aim of the present consensus statement is to provide guidance, cohesion, and standardization of best practices for thermal ablation procedures of thyroid nodules.<\/pee> <\/p>\n

\t\t <\/p>\n
Brazilian Society of Interventional Radiology and Endovascular Surgery<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
August<\/b>2023<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

General principles for the safe performance, training and adoption of ablation techniques for benign thyroid nodules: An American Thyroid Association Statement<\/h2>\n

This consensus statement is organized around three key themes: i. safety of ablation techniques and their implementation, ii. optimal skillset criteria for proceduralists performing ablative procedures, and iii. defining expectations of success for this treatment option given its unique risks and benefits.<\/pee> <\/p>\n

\t\t <\/p>\n
American Thyroid Association<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
FEBRUARY<\/b>2022<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

The Clinical Utility of Minimally Invasive Interventional Procedures in the Management of Benign and Malignant Thyroid Lesions<\/h2>\n

Thyroid nodules are very common in the general population. Although many of these are benign in nature, the nodules may be large and cause obstructive symptoms or cosmetic concerns. To a lesser extent, some nodules are cancerous. Surgery is considered the standard treatment for large or active thyroid nodules as well as cancerous nodules. Some nodules may need treatment with radioactive iodine. In this review, we discuss alternative (nonsurgical) treatment options to treat benign and \u201csome\u201d cancerous thyroid lesions.<\/pee> <\/p>\n

\t\t <\/p>\n
American Association of Clinical Endocrinology Disease State Clinical Review<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
November<\/b>2022<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation<\/h2>\n

Radiofrequency ablation (RFA) is a minimally invasive management strategy that has been widely applied for benign and recurrent malignant thyroid lesions as an alternative to surgery in Taiwan. Members of academic societies for specialists in interventional radiology, endocrinology, and endocrine surgery collaborated to develop the first consensus regarding thyroid RFA in Taiwan.<\/pee> <\/p>\n

\t\t <\/p>\n
2022 Taiwan clinical multicenter expert consensus<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
MAY <\/b>2021<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions<\/h2>\n

\t The growing detection of papillary thyroid microcarcinomas (PTMCs) is paralleled by an increase in surgical procedures. Due to the frequent indolent nature, cost, and risk of surgery, active surveillance (AS) and ultrasound-guided minimally invasive treatments (MITs) are in suitable cases of incidental PTMC proposed as alternatives to thyroidectomy. <\/pee> <\/p>\n

\t\t <\/p>\n
In: European Thyroid Journal Volume 10 Issue 3 (2021)<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
December<\/b>2021<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease<\/h2>\n

The use of ultrasound-guided ablation procedures to treat both benign and malignant thyroid conditions is gaining increasing interest. This document has been developed as an international interdisciplinary evidence-based statement with a primary focus on radiofrequency ablation and is intended to serve as a manual for best practice application of ablation technologies.<\/pee> <\/p>\n

\t\t <\/p>\n
American Head and Neck Society Endocrine Surgery Section with the Asian Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, Thyroid Nodules Therapies Association<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
June<\/b>2020<\/span><\/div>\n

<\/p>\n

<\/p>\n

2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules<\/h2>\n

Standard therapeutic approaches for benign thyroid lesions that warrant intervention are surgery for cold and either surgery or radioiodine for autonomously functioning thyroid nodules (AFTN). Image-guided thermal ablation (TA) procedures are increasingly proposed as therapy options for selected clinical conditions. Due to mounting scientific evidence and widening availability, ETA considered it appropriate to develop guidelines for the use of TA in adult patients\u2026.<\/pee> <\/p>\n

<\/p>\n
European Thyroid Association <\/div>\n

Read More <\/a> <\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
September<\/b>2020<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force<\/h2>\n

Radiofrequency ablation (RFA) is a thermal ablation technique widely used for the management of benign thyroid nodules. To date, five academic societies in various countries have reported clinical practice guidelines, opinion statements, or recommendations regarding the use of thyroid RFA.<\/pee> <\/p>\n

\t\t <\/p>\n
Asian Conference on Tumor Ablation Task Force<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section][et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
September<\/b>2020<\/span><\/div>\n

<\/p>\n

\t<\/p>\n

Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors<\/h2>\n

As a treatment option for cancer, thermal ablation has satisfactory effects on many types of solid tumors (such as liver and renal cancers). However, its clinical applications for the treatment of thyroid nodules and metastatic cervical lymph nodes are still under debate both in China and abroad. In 2015, the \u201cZhejiang Expert consensus on thermal ablation for thyroid benign nodules, microcarcinoma, and metastatic cervical lymph nodes (2015 edition),\u201d was released by the Thyroid Cancer Committee of Zhejiang Anti-Cancer Association, China\u2026<\/pee> <\/p>\n

\t\t <\/p>\n
Thyroid Tumor Ablation Experts Group of Chinese Medical Doctor Association<\/div>\n

\t\t Read More <\/a>\t <\/div>\n

\t \t<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
February<\/b>2019<\/span><\/div>\n

<\/p>\n

<\/p>\n

Radiofrequency ablation of thyroid nodules: \u201cGood Clinical Practice Recommendations\u201d for Austria<\/h2>\n

An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (\u00d6SDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (\u00d6GES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH)<\/pee> <\/p>\n

<\/p>\n
Austrian Thyroid Association, Austrian Society for Nuclear Medicine and Molecular Imaging, Austrian Society for Endocrinology and Metabolism, Surgical Endocrinology Working Group of the Austrian Surgical Society<\/div>\n

Read More <\/a> <\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
March<\/b>2019<\/span><\/div>\n

<\/p>\n

<\/p>\n

Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group<\/h2>\n

Benign thyroid nodules are a common clinical occurrence and usually do not require treatment unless symptomatic. During the last years, ultrasound-guided minimally invasive treatments (MIT) gained an increasing role in the management of nodules causing local symptoms\u2026<\/pee> <\/p>\n

<\/p>\n
Italian Minimally Invasive Treatments of the Thyroid group<\/div>\n

Read More <\/a> <\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
June<\/b>2018<\/span><\/div>\n

<\/p>\n

<\/p>\n

2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology<\/h2>\n

Thermal ablation using radiofrequency is a new, minimally invasive modality employed as an alternative to surgery in patients with benign thyroid nodules and recurrent thyroid cancers. The Task Force Committee of the Korean Society of Thyroid Radiology (KSThR) developed recommendations for the optimal use of radiofrequency ablation for thyroid tumors in 2012. As new meaningful evidences have accumulated, KSThR decided to revise the guidelines.<\/pee> <\/p>\n

<\/p>\n
Korean Society of Thyroid Radiology<\/div>\n

Read More <\/a> <\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

<\/p>\n
June<\/b>2016<\/span><\/div>\n

<\/p>\n

<\/p>\n

Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules<\/h2>\n

Evidence-based recommendations on ultrasound-guided percutaneous radiofrequency ablation for treating benign thyroid nodules in adults. This involves using heat energy to destroy tissue in the nodules.<\/pee> <\/p>\n

<\/p>\n
National Institute for Health and Care Excellence<\/div>\n

Read More <\/a> <\/div>\n

<\/div>\n

<\/div>\n

[\/et_pb_fullwidth_code][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":215,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","pmpro_default_level":"","_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":"","_tec_slr_enabled":"","_tec_slr_layout":""},"class_list":["post-2733","page","type-page","status-publish","hentry","pmpro-has-access"],"yoast_head":"\nGuidelines & Statements - NASOIE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cressettech1.com\/?page_id=2733\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guidelines & Statements - NASOIE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cressettech1.com\/?page_id=2733\" \/>\n<meta property=\"og:site_name\" content=\"NASOIE\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-04T12:50:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nasoie.com\/wp-content\/themes\/Divi\/images\/gl.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733\",\"url\":\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733\",\"name\":\"Guidelines & Statements - NASOIE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cressettech1.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nasoie.com\\\/wp-content\\\/themes\\\/Divi\\\/images\\\/gl.jpg\",\"datePublished\":\"2025-05-09T09:10:43+00:00\",\"dateModified\":\"2025-08-04T12:50:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733#primaryimage\",\"url\":\"https:\\\/\\\/nasoie.com\\\/wp-content\\\/themes\\\/Divi\\\/images\\\/gl.jpg\",\"contentUrl\":\"https:\\\/\\\/nasoie.com\\\/wp-content\\\/themes\\\/Divi\\\/images\\\/gl.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cressettech1.com\\\/?page_id=2733#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cressettech1.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guidelines & Statements\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cressettech1.com\\\/#website\",\"url\":\"https:\\\/\\\/cressettech1.com\\\/\",\"name\":\"NASOIE\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cressettech1.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guidelines & Statements - NASOIE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cressettech1.com\/?page_id=2733","og_locale":"en_US","og_type":"article","og_title":"Guidelines & Statements - NASOIE","og_url":"https:\/\/cressettech1.com\/?page_id=2733","og_site_name":"NASOIE","article_modified_time":"2025-08-04T12:50:00+00:00","og_image":[{"url":"https:\/\/nasoie.com\/wp-content\/themes\/Divi\/images\/gl.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cressettech1.com\/?page_id=2733","url":"https:\/\/cressettech1.com\/?page_id=2733","name":"Guidelines & Statements - NASOIE","isPartOf":{"@id":"https:\/\/cressettech1.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cressettech1.com\/?page_id=2733#primaryimage"},"image":{"@id":"https:\/\/cressettech1.com\/?page_id=2733#primaryimage"},"thumbnailUrl":"https:\/\/nasoie.com\/wp-content\/themes\/Divi\/images\/gl.jpg","datePublished":"2025-05-09T09:10:43+00:00","dateModified":"2025-08-04T12:50:00+00:00","breadcrumb":{"@id":"https:\/\/cressettech1.com\/?page_id=2733#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cressettech1.com\/?page_id=2733"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cressettech1.com\/?page_id=2733#primaryimage","url":"https:\/\/nasoie.com\/wp-content\/themes\/Divi\/images\/gl.jpg","contentUrl":"https:\/\/nasoie.com\/wp-content\/themes\/Divi\/images\/gl.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/cressettech1.com\/?page_id=2733#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cressettech1.com\/"},{"@type":"ListItem","position":2,"name":"Guidelines & Statements"}]},{"@type":"WebSite","@id":"https:\/\/cressettech1.com\/#website","url":"https:\/\/cressettech1.com\/","name":"NASOIE","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cressettech1.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"ticketed":false,"_links":{"self":[{"href":"https:\/\/cressettech1.com\/index.php?rest_route=\/wp\/v2\/pages\/2733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cressettech1.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cressettech1.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cressettech1.com\/index.php?rest_route=\/wp\/v2\/users\/215"}],"replies":[{"embeddable":true,"href":"https:\/\/cressettech1.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2733"}],"version-history":[{"count":20,"href":"https:\/\/cressettech1.com\/index.php?rest_route=\/wp\/v2\/pages\/2733\/revisions"}],"predecessor-version":[{"id":2785,"href":"https:\/\/cressettech1.com\/index.php?rest_route=\/wp\/v2\/pages\/2733\/revisions\/2785"}],"wp:attachment":[{"href":"https:\/\/cressettech1.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}